CA2058441A1 - R-h-gm-csf cristallise et methode de preparation - Google Patents
R-h-gm-csf cristallise et methode de preparationInfo
- Publication number
- CA2058441A1 CA2058441A1 CA2058441A CA2058441A CA2058441A1 CA 2058441 A1 CA2058441 A1 CA 2058441A1 CA 2058441 A CA2058441 A CA 2058441A CA 2058441 A CA2058441 A CA 2058441A CA 2058441 A1 CA2058441 A1 CA 2058441A1
- Authority
- CA
- Canada
- Prior art keywords
- csf
- crystalline
- preparation
- crystals
- making
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/145—Colony stimulating factor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Glass Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Abstract
La présente invention porte sur une forme cristalline du facteur stimulant les colonies de granulocytes-macrophages humain recombinant (r-h-GM-CSF) et sur des méthodes pour obtenir ces cristaux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US362,187 | 1989-06-06 | ||
US07/362,187 US5109119A (en) | 1989-06-06 | 1989-06-06 | Crystalline r-h-gm-csf and method |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2058441A1 true CA2058441A1 (fr) | 1990-12-07 |
CA2058441C CA2058441C (fr) | 1997-12-16 |
Family
ID=23425041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002058441A Expired - Fee Related CA2058441C (fr) | 1989-06-06 | 1990-06-04 | R-h-gm-csf cristallise et methode de preparation |
Country Status (14)
Country | Link |
---|---|
US (2) | US5109119A (fr) |
EP (3) | EP0402070B1 (fr) |
JP (1) | JP2572160B2 (fr) |
KR (1) | KR960004454B1 (fr) |
AT (1) | ATE110113T1 (fr) |
AU (1) | AU644083B2 (fr) |
CA (1) | CA2058441C (fr) |
DE (1) | DE69011586T2 (fr) |
DK (1) | DK0402070T3 (fr) |
FI (1) | FI915709A0 (fr) |
HK (1) | HK184996A (fr) |
HU (1) | HU209871B (fr) |
NO (1) | NO914771D0 (fr) |
WO (1) | WO1990015151A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69031914T2 (de) * | 1989-08-11 | 1998-07-30 | Amrad Corp. Ltd., Kew, Victoria | Rezeptor für granulozyten-macrophagen-koloniestimulierungsfaktor und seine derivate |
EP0955365A3 (fr) | 1992-06-09 | 2000-12-20 | Chiron Corporation | Cristallisation du M-CSF |
US5581476A (en) * | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
US6004549A (en) * | 1994-12-14 | 1999-12-21 | Schering Corporation | Crystalline protein controlled release compositions |
US6646110B2 (en) * | 2000-01-10 | 2003-11-11 | Maxygen Holdings Ltd. | G-CSF polypeptides and conjugates |
US6831158B2 (en) * | 2000-01-10 | 2004-12-14 | Maxygen Holdings Ltd. | G-CSF conjugates |
US6555660B2 (en) * | 2000-01-10 | 2003-04-29 | Maxygen Holdings Ltd. | G-CSF conjugates |
PE20020394A1 (es) * | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
MXPA04000231A (es) * | 2001-07-11 | 2004-05-04 | Maxygen Holdings Ltd | Conjugados del factor de estimulacion de colonias de granulocitos. |
US7765302B2 (en) * | 2003-06-30 | 2010-07-27 | Nortel Networks Limited | Distributed call server supporting communication sessions in a communication system and method |
EP1768700B1 (fr) * | 2004-07-16 | 2010-12-15 | Nektar Therapeutics | Conjugues comprenant gm-csf et un polymer |
CA2607844C (fr) | 2005-06-01 | 2012-07-10 | Maxygen Holdings Ltd. | Polypeptides g-csf pegyles et procedes de production correspondants |
WO2007102946A2 (fr) * | 2006-01-23 | 2007-09-13 | Amgen Inc. | Polypeptides cristallins |
US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU588819B2 (en) * | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
IL77080A (en) * | 1984-11-20 | 1998-02-08 | Schering Biotech Corp | Polypeptides showing activity of human growth factor of macrophage granulocyte and eosinophils Vectors and cells transformed for their preparation and pharmaceutical preparations containing or |
JP2595216B2 (ja) * | 1986-12-12 | 1997-04-02 | 日清製粉株式会社 | α―アミラーゼインヒビターの結晶の製造方法 |
US4912200A (en) * | 1987-05-11 | 1990-03-27 | Schering Corporation | Extraction of granulocyte macrophage colony stimulating factor from bacteria |
DE68921186T2 (de) * | 1988-05-31 | 1995-06-14 | Cetus Oncology Corp | Verfahren zur gewinnung von heterologe proteine enthaltenden refraktilkörpern aus mikrobiellen wirten. |
-
1989
- 1989-06-06 US US07/362,187 patent/US5109119A/en not_active Expired - Fee Related
-
1990
- 1990-06-04 HU HU904835A patent/HU209871B/hu not_active IP Right Cessation
- 1990-06-04 WO PCT/US1990/003027 patent/WO1990015151A1/fr not_active Application Discontinuation
- 1990-06-04 KR KR1019910700126A patent/KR960004454B1/ko not_active IP Right Cessation
- 1990-06-04 AU AU58348/90A patent/AU644083B2/en not_active Ceased
- 1990-06-04 DE DE69011586T patent/DE69011586T2/de not_active Expired - Fee Related
- 1990-06-04 EP EP90306042A patent/EP0402070B1/fr not_active Expired - Lifetime
- 1990-06-04 DK DK90306042.4T patent/DK0402070T3/da active
- 1990-06-04 JP JP2509088A patent/JP2572160B2/ja not_active Expired - Lifetime
- 1990-06-04 EP EP19930108721 patent/EP0561429A1/fr not_active Withdrawn
- 1990-06-04 CA CA002058441A patent/CA2058441C/fr not_active Expired - Fee Related
- 1990-06-04 AT AT90306042T patent/ATE110113T1/de not_active IP Right Cessation
- 1990-06-04 EP EP90909434A patent/EP0476022A1/fr active Pending
-
1991
- 1991-12-04 FI FI915709A patent/FI915709A0/fi not_active Application Discontinuation
- 1991-12-04 NO NO914771A patent/NO914771D0/no unknown
-
1995
- 1995-06-07 US US08/482,168 patent/US5616555A/en not_active Expired - Lifetime
-
1996
- 1996-10-03 HK HK184996A patent/HK184996A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI915709A0 (fi) | 1991-12-04 |
HU209871B (en) | 1994-11-28 |
AU5834890A (en) | 1991-01-07 |
WO1990015151A1 (fr) | 1990-12-13 |
JP2572160B2 (ja) | 1997-01-16 |
EP0402070A1 (fr) | 1990-12-12 |
EP0561429A1 (fr) | 1993-09-22 |
NO914771L (no) | 1991-12-04 |
AU644083B2 (en) | 1993-12-02 |
KR920700293A (ko) | 1992-02-19 |
EP0402070B1 (fr) | 1994-08-17 |
HUT58822A (en) | 1992-03-30 |
NO914771D0 (no) | 1991-12-04 |
KR960004454B1 (ko) | 1996-04-06 |
US5109119A (en) | 1992-04-28 |
US5616555A (en) | 1997-04-01 |
HU904835D0 (en) | 1992-02-28 |
ATE110113T1 (de) | 1994-09-15 |
DE69011586T2 (de) | 1995-03-02 |
JPH04502014A (ja) | 1992-04-09 |
DK0402070T3 (da) | 1994-09-12 |
CA2058441C (fr) | 1997-12-16 |
DE69011586D1 (de) | 1994-09-22 |
EP0476022A1 (fr) | 1992-03-25 |
HK184996A (en) | 1996-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7746487A (en) | Surgical prosthesis | |
AU4897085A (en) | Intracanalicular implant | |
AU8308987A (en) | Implant | |
AU3756889A (en) | Method for transforming plants via the shoot apex | |
AU4376089A (en) | Improved retainer for surgical sutures | |
CA2058441A1 (fr) | R-h-gm-csf cristallise et methode de preparation | |
AU6254190A (en) | Growth hormone-releasing factor analogs | |
AU3672189A (en) | Fishhook and producing method of the same | |
AU2070088A (en) | Surgery forceps | |
AU590843B2 (en) | Pesticidal compositions and process for preparation thereof | |
AU8218187A (en) | Colony-stimulating factor and method for preparation thereof | |
AU590942B2 (en) | Method of manufacturing dichroic antenna structures | |
AU6728690A (en) | Method for inhibiting the growth of salmonella | |
AU2254392A (en) | Method for the preparation of niobium nitride | |
AU641190B2 (en) | Process for manufacture of 1,1-dichlorotetrafluoroethane | |
AU2759188A (en) | Method of manufacturing ceramic artifact | |
AU2992189A (en) | Method of preparing 4,4'-methylenedianiline | |
AU5689190A (en) | Method of preparing n-oxo-tetrahydro-beta-carbolines | |
AU3665289A (en) | Polysilazanes, process for their preparation | |
AU590431B2 (en) | A method for the preparation of 2,4-diamino-3-oxy-6- piperidyl-pyrimidine | |
AU2330488A (en) | Improved method for the preparation of anilinofumarate | |
AU4130089A (en) | Method for the manufacture of laminated elements | |
AU7652487A (en) | Process for the preparation of 2,4-diamino-5-benzylpyrimidines | |
AU1297592A (en) | Method of preparing polyethercyclicopolyols | |
AU1297492A (en) | Method of preparing polyethercyclicpolyols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |